carbidopa has been researched along with Scleroderma, Localized in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joly, P; Lampert, A; Lauret, P; Ortoli, JC; Thomine, E | 1 |
| Joly, P; Lampert, A; Lauret, P; Thomine, E | 1 |
| Auffranc, JC; Berbis, P; Fabre, JF; Garnier, JP; Privat, Y | 1 |
1 review(s) available for carbidopa and Scleroderma, Localized
| Article | Year |
|---|---|
[Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam].
Topics: Aged; Carbidopa; Drug Therapy, Combination; Eosinophilia; Flunitrazepam; Humans; Male; Scleroderma, Localized; Skin Diseases, Vesiculobullous; Tryptophan | 1992 |
2 other study(ies) available for carbidopa and Scleroderma, Localized
| Article | Year |
|---|---|
Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Chronic Disease; Depression; Drug Therapy, Combination; Eosinophilia-Myalgia Syndrome; Humans; Male; Parkinson Disease; Scleroderma, Localized | 1991 |
[Sclerodermiform and poikilodermal syndrome observed during treatment with carbidopa and 5-hydroxytryptophan].
Topics: Aged; Carbidopa; Drug Therapy, Combination; Humans; Male; Parkinson Disease; Photosensitivity Disorders; Pigmentation Disorders; Scleroderma, Localized | 1985 |